世界のテリフルノミド市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Teriflunomide Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5602
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、テリフルノミドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、粉末）、用途別市場規模（免疫抑制、がん治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・テリフルノミドの市場動向
・企業の競争状況、市場シェア
・テリフルノミドの種類別市場規模（錠剤、粉末）
・テリフルノミドの用途別市場規模（免疫抑制、がん治療）
・テリフルノミドの北米市場規模2016-2027（アメリカ、カナダ）
・テリフルノミドのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・テリフルノミドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・テリフルノミドの中南米市場規模2016-2027（メキシコ、ブラジル）
・テリフルノミドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi Aventis、Genzyme Corporation、Amneal Pharmaceuticals NY LC、Glenmark Pharmaceuticals、Msn Laboratories Private Limited）
・結論

Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.

Market Analysis and Insights: Global Teriflunomide Market
The global Teriflunomide market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Teriflunomide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Teriflunomide market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Teriflunomide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Teriflunomide market.

Global Teriflunomide Scope and Market Size
Teriflunomide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Teriflunomide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
Powder

Segment by Application
Immunosuppression
Cancer Treatment

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi Aventis
Genzyme Corporation
Amneal Pharmaceuticals NY LC

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Teriflunomide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Teriflunomide Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunosuppression
1.3.3 Cancer Treatment
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Teriflunomide Market Perspective (2016-2027)
2.2 Teriflunomide Growth Trends by Regions
2.2.1 Teriflunomide Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Teriflunomide Historic Market Share by Regions (2016-2021)
2.2.3 Teriflunomide Forecasted Market Size by Regions (2022-2027)
2.3 Teriflunomide Industry Dynamic
2.3.1 Teriflunomide Market Trends
2.3.2 Teriflunomide Market Drivers
2.3.3 Teriflunomide Market Challenges
2.3.4 Teriflunomide Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Teriflunomide Players by Revenue
3.1.1 Global Top Teriflunomide Players by Revenue (2016-2021)
3.1.2 Global Teriflunomide Revenue Market Share by Players (2016-2021)
3.2 Global Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Teriflunomide Revenue
3.4 Global Teriflunomide Market Concentration Ratio
3.4.1 Global Teriflunomide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Teriflunomide Revenue in 2020
3.5 Teriflunomide Key Players Head office and Area Served
3.6 Key Players Teriflunomide Product Solution and Service
3.7 Date of Enter into Teriflunomide Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Teriflunomide Breakdown Data by Type
4.1 Global Teriflunomide Historic Market Size by Type (2016-2021)
4.2 Global Teriflunomide Forecasted Market Size by Type (2022-2027)

5 Teriflunomide Breakdown Data by Application
5.1 Global Teriflunomide Historic Market Size by Application (2016-2021)
5.2 Global Teriflunomide Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Teriflunomide Market Size (2016-2027)
6.2 North America Teriflunomide Market Size by Type
6.2.1 North America Teriflunomide Market Size by Type (2016-2021)
6.2.2 North America Teriflunomide Market Size by Type (2022-2027)
6.2.3 North America Teriflunomide Market Size by Type (2016-2027)
6.3 North America Teriflunomide Market Size by Application
6.3.1 North America Teriflunomide Market Size by Application (2016-2021)
6.3.2 North America Teriflunomide Market Size by Application (2022-2027)
6.3.3 North America Teriflunomide Market Size by Application (2016-2027)
6.4 North America Teriflunomide Market Size by Country
6.4.1 North America Teriflunomide Market Size by Country (2016-2021)
6.4.2 North America Teriflunomide Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Teriflunomide Market Size (2016-2027)
7.2 Europe Teriflunomide Market Size by Type
7.2.1 Europe Teriflunomide Market Size by Type (2016-2021)
7.2.2 Europe Teriflunomide Market Size by Type (2022-2027)
7.2.3 Europe Teriflunomide Market Size by Type (2016-2027)
7.3 Europe Teriflunomide Market Size by Application
7.3.1 Europe Teriflunomide Market Size by Application (2016-2021)
7.3.2 Europe Teriflunomide Market Size by Application (2022-2027)
7.3.3 Europe Teriflunomide Market Size by Application (2016-2027)
7.4 Europe Teriflunomide Market Size by Country
7.4.1 Europe Teriflunomide Market Size by Country (2016-2021)
7.4.2 Europe Teriflunomide Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Teriflunomide Market Size (2016-2027)
8.2 Asia-Pacific Teriflunomide Market Size by Type
8.2.1 Asia-Pacific Teriflunomide Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Teriflunomide Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Teriflunomide Market Size by Type (2016-2027)
8.3 Asia-Pacific Teriflunomide Market Size by Application
8.3.1 Asia-Pacific Teriflunomide Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Teriflunomide Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Teriflunomide Market Size by Application (2016-2027)
8.4 Asia-Pacific Teriflunomide Market Size by Region
8.4.1 Asia-Pacific Teriflunomide Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Teriflunomide Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Teriflunomide Market Size (2016-2027)
9.2 Latin America Teriflunomide Market Size by Type
9.2.1 Latin America Teriflunomide Market Size by Type (2016-2021)
9.2.2 Latin America Teriflunomide Market Size by Type (2022-2027)
9.2.3 Latin America Teriflunomide Market Size by Type (2016-2027)
9.3 Latin America Teriflunomide Market Size by Application
9.3.1 Latin America Teriflunomide Market Size by Application (2016-2021)
9.3.2 Latin America Teriflunomide Market Size by Application (2022-2027)
9.3.3 Latin America Teriflunomide Market Size by Application (2016-2027)
9.4 Latin America Teriflunomide Market Size by Country
9.4.1 Latin America Teriflunomide Market Size by Country (2016-2021)
9.4.2 Latin America Teriflunomide Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Teriflunomide Market Size (2016-2027)
10.2 Middle East & Africa Teriflunomide Market Size by Type
10.2.1 Middle East & Africa Teriflunomide Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Teriflunomide Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Teriflunomide Market Size by Type (2016-2027)
10.3 Middle East & Africa Teriflunomide Market Size by Application
10.3.1 Middle East & Africa Teriflunomide Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Teriflunomide Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Teriflunomide Market Size by Application (2016-2027)
10.4 Middle East & Africa Teriflunomide Market Size by Country
10.4.1 Middle East & Africa Teriflunomide Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Teriflunomide Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi Aventis
11.1.1 Sanofi Aventis Company Details
11.1.2 Sanofi Aventis Business Overview
11.1.3 Sanofi Aventis Teriflunomide Introduction
11.1.4 Sanofi Aventis Revenue in Teriflunomide Business (2016-2021)
11.1.5 Sanofi Aventis Recent Development
11.2 Genzyme Corporation
11.2.1 Genzyme Corporation Company Details
11.2.2 Genzyme Corporation Business Overview
11.2.3 Genzyme Corporation Teriflunomide Introduction
11.2.4 Genzyme Corporation Revenue in Teriflunomide Business (2016-2021)
11.2.5 Genzyme Corporation Recent Development
11.3 Amneal Pharmaceuticals NY LC
11.3.1 Amneal Pharmaceuticals NY LC Company Details
11.3.2 Amneal Pharmaceuticals NY LC Business Overview
11.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Introduction
11.3.4 Amneal Pharmaceuticals NY LC Revenue in Teriflunomide Business (2016-2021)
11.3.5 Amneal Pharmaceuticals NY LC Recent Development
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Details
11.4.2 Glenmark Pharmaceuticals Business Overview
11.4.3 Glenmark Pharmaceuticals Teriflunomide Introduction
11.4.4 Glenmark Pharmaceuticals Revenue in Teriflunomide Business (2016-2021)
11.4.5 Glenmark Pharmaceuticals Recent Development
11.5 Msn Laboratories Private Limited
11.5.1 Msn Laboratories Private Limited Company Details
11.5.2 Msn Laboratories Private Limited Business Overview
11.5.3 Msn Laboratories Private Limited Teriflunomide Introduction
11.5.4 Msn Laboratories Private Limited Revenue in Teriflunomide Business (2016-2021)
11.5.5 Msn Laboratories Private Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Teriflunomide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Powder
Table 4. Global Teriflunomide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Teriflunomide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Teriflunomide Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Teriflunomide Market Share by Regions (2016-2021)
Table 8. Global Teriflunomide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Teriflunomide Market Share by Regions (2022-2027)
Table 10. Teriflunomide Market Trends
Table 11. Teriflunomide Market Drivers
Table 12. Teriflunomide Market Challenges
Table 13. Teriflunomide Market Restraints
Table 14. Global Teriflunomide Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Teriflunomide Market Share by Players (2016-2021)
Table 16. Global Top Teriflunomide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teriflunomide as of 2020)
Table 17. Ranking of Global Top Teriflunomide Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Teriflunomide Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Teriflunomide Product Solution and Service
Table 21. Date of Enter into Teriflunomide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Teriflunomide Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Teriflunomide Revenue Market Share by Type (2016-2021)
Table 25. Global Teriflunomide Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Teriflunomide Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Teriflunomide Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Teriflunomide Revenue Market Share by Application (2016-2021)
Table 29. Global Teriflunomide Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Teriflunomide Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Teriflunomide Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Teriflunomide Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Teriflunomide Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Teriflunomide Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Teriflunomide Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Teriflunomide Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Teriflunomide Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Teriflunomide Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Teriflunomide Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Teriflunomide Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Teriflunomide Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Teriflunomide Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Teriflunomide Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Teriflunomide Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Teriflunomide Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Teriflunomide Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Teriflunomide Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Teriflunomide Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Teriflunomide Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Teriflunomide Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Aventis Company Details
Table 62. Sanofi Aventis Business Overview
Table 63. Sanofi Aventis Teriflunomide Product
Table 64. Sanofi Aventis Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
Table 65. Sanofi Aventis Recent Development
Table 66. Genzyme Corporation Company Details
Table 67. Genzyme Corporation Business Overview
Table 68. Genzyme Corporation Teriflunomide Product
Table 69. Genzyme Corporation Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
Table 70. Genzyme Corporation Recent Development
Table 71. Amneal Pharmaceuticals NY LC Company Details
Table 72. Amneal Pharmaceuticals NY LC Business Overview
Table 73. Amneal Pharmaceuticals NY LC Teriflunomide Product
Table 74. Amneal Pharmaceuticals NY LC Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
Table 75. Amneal Pharmaceuticals NY LC Recent Development
Table 76. Glenmark Pharmaceuticals Company Details
Table 77. Glenmark Pharmaceuticals Business Overview
Table 78. Glenmark Pharmaceuticals Teriflunomide Product
Table 79. Glenmark Pharmaceuticals Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
Table 80. Glenmark Pharmaceuticals Recent Development
Table 81. Msn Laboratories Private Limited Company Details
Table 82. Msn Laboratories Private Limited Business Overview
Table 83. Msn Laboratories Private Limited Teriflunomide Product
Table 84. Msn Laboratories Private Limited Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
Table 85. Msn Laboratories Private Limited Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Teriflunomide Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Powder Features
Figure 4. Global Teriflunomide Market Share by Application: 2020 VS 2027
Figure 5. Immunosuppression Case Studies
Figure 6. Cancer Treatment Case Studies
Figure 7. Teriflunomide Report Years Considered
Figure 8. Global Teriflunomide Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Teriflunomide Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Teriflunomide Market Share by Regions: 2020 VS 2027
Figure 11. Global Teriflunomide Market Share by Regions (2022-2027)
Figure 12. Global Teriflunomide Market Share by Players in 2020
Figure 13. Global Top Teriflunomide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teriflunomide as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Teriflunomide Revenue in 2020
Figure 15. Global Teriflunomide Revenue Market Share by Type (2016-2021)
Figure 16. Global Teriflunomide Revenue Market Share by Type (2022-2027)
Figure 17. North America Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Teriflunomide Market Share by Type (2016-2027)
Figure 19. North America Teriflunomide Market Share by Application (2016-2027)
Figure 20. North America Teriflunomide Market Share by Country (2016-2027)
Figure 21. United States Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Teriflunomide Market Share by Type (2016-2027)
Figure 25. Europe Teriflunomide Market Share by Application (2016-2027)
Figure 26. Europe Teriflunomide Market Share by Country (2016-2027)
Figure 27. Germany Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Teriflunomide Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Teriflunomide Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Teriflunomide Market Share by Region (2016-2027)
Figure 37. China Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Teriflunomide Market Share by Type (2016-2027)
Figure 45. Latin America Teriflunomide Market Share by Application (2016-2027)
Figure 46. Latin America Teriflunomide Market Share by Country (2016-2027)
Figure 47. Mexico Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Teriflunomide Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Teriflunomide Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Teriflunomide Market Share by Country (2016-2027)
Figure 53. Turkey Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Sanofi Aventis Revenue Growth Rate in Teriflunomide Business (2016-2021)
Figure 57. Genzyme Corporation Revenue Growth Rate in Teriflunomide Business (2016-2021)
Figure 58. Amneal Pharmaceuticals NY LC Revenue Growth Rate in Teriflunomide Business (2016-2021)
Figure 59. Glenmark Pharmaceuticals Revenue Growth Rate in Teriflunomide Business (2016-2021)
Figure 60. Msn Laboratories Private Limited Revenue Growth Rate in Teriflunomide Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

以下、関連資料のご紹介

世界のテリフルノミド市場規模・現状・予測（2021年-2027年）

Global Teriflunomide Market Size, Status and Forecast 2021-2027
QYR2104Z5602 2021年4月 98Pages
QYResearch社発行の本調査資料では、テリフルノミドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、粉末）、用途別市場規模（免疫抑制、がん治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南...

世界のクロファラビン市場規模・現状・予測（2021年-2027年）

Global Clofarabine Market Size, Status and Forecast 2021-2027
QYR2104Z1384 2021年4月 99Pages
QYResearch社発行の本調査資料では、クロファラビンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エボルトラ、クロファラビン）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

Global Exostosin 1/2 Heterodimer Market Size, Status and Forecast 2021-2027
QYR2104Z2272 2021年4月 92Pages
QYResearch社発行の本調査資料では、エキソストシン1/2ヘテロダイマーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療薬市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5519 2021年4月 95Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の自動車におけるPLM市場規模・現状・予測（2021年-2027年）

Global PLM in Automotive Market Size, Status and Forecast 2021-2027
QYR2104Z4659 2021年4月 90Pages
QYResearch社発行の本調査資料では、自動車におけるPLMのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CAD、CFD、cPDM、DM、EDA、FEA、NC）、用途別市場規模（乗用車、商用車）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z0095 2021年4月 99Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

Global Micafungin Sodium for Injection Market Size, Status and Forecast 2021-2027
QYR2104Z3743 2021年4月 97Pages
QYResearch社発行の本調査資料では、注射用ミカファンギンナトリウムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（50mg使い捨てバイアル、100mg使い捨てバイアル）、用途別市場規模（カンジダ血症、呼吸器真菌症、胃腸真菌症）、主要地域...

世界のテリフルノミド市場規模・現状・予測（2021年-2027年） Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator. Market Analysis and Insights: Global Teriflunomide Market The global Teriflunomide market size is projected to reach US$ XX mill…
世界の下咽頭がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypopharyngeal Cancer Treatment Market The global Hypopharyngeal Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
世界の陰茎がん治療市場規模・現状・予測（2021年-2027年） Therapy of penile cancer. Market Analysis and Insights: Global Penile Cancer Treatment Market The global Penile Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
世界の非血液がん治療市場規模・現状・予測（2021年-2027年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…